Muscle

  • XW02 Muscle
    • XW020 Open
      • XW020D Engineered Allogeneic Thymus Tissue
        • XW020D8 Introduction of Engineered Allogeneic Thymus Tissue into Muscle, Open Approach, New Technology Group 8
    • XW023 Percutaneous
      • XW023S COVID-19 Vaccine Dose 1
        • XW023S6 Introduction of COVID-19 Vaccine Dose 1 into Muscle, Percutaneous Approach, New Technology Group 6
      • XW023T COVID-19 Vaccine Dose 2
        • XW023T6 Introduction of COVID-19 Vaccine Dose 2 into Muscle, Percutaneous Approach, New Technology Group 6
      • XW023U COVID-19 Vaccine
        • XW023U6 Introduction of COVID-19 Vaccine into Muscle, Percutaneous Approach, New Technology Group 6
      • XW023V COVID-19 Vaccine Dose 3
        • XW023V7 Introduction of COVID-19 Vaccine Dose 3 into Muscle, Percutaneous Approach, New Technology Group 7
      • XW023W COVID-19 Vaccine Booster
        • XW023W7 Introduction of COVID-19 Vaccine Booster into Muscle, Percutaneous Approach, New Technology Group 7
      • XW023X Tixagevimab and Cilgavimab Monoclonal Antibody
        • XW023X7 Introduction of Tixagevimab and Cilgavimab Monoclonal Antibody into Muscle, Percutaneous Approach, New Technology Group 7
      • XW023Y Other New Technology Monoclonal Antibody
        • XW023Y7 Introduction of Other New Technology Monoclonal Antibody into Muscle, Percutaneous Approach, New Technology Group 7